SLS

Conviction 65HealthcareScan · Thu, Sep 24, 2026

Bullish engulfing

SELLAS Life Sciences Group, Inc. (SLS) closed at $11.99 (+4.04%) on Sep 24, 2026. Its latest daily candle is a bullish engulfing. Price is below its 50-day and above its 200-day moving average. RSI(14) 47, RS Rating 99, -22.5% from its 52-week high, +175.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SLS$11.99+4.04%

ResistanceSupportVol 14

Vol MA14 6.99M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

WSB mentions · 24h changelatest -50.00%· 4 mentions

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

SELLAS Life Sciences Group, Inc.PHARMACEUTICAL PREPARATIONSwww.sellaslifesciences.com ↗

Price11.99

Change+4.04%

Gap-1.82%

Rel volume0.89×

Avg volume7.26M

Avg $ vol92.05M

SMA 2012.71

SMA 5012.40

SMA 2007.49

Price vs 50-3.37%

Price vs 200+60.02%

MA stackmixed

50/200 cross—

Supertrendup · 10.94

RSI (14)47

MACD hist-0.15

MACD cross—

Stoch %K / %D33 / 29

ADX (14)22

+DI / −DI16 / 20

RSI divergence—

MACD divergence—

ATR %8.31%

ADR %7.65%

52w high15.46

52w low1.39

From 52w high-22.48%

Above 52w low+762.23%

New 52w highNo

SqueezeOff

Bollinger width37.11%

%B0.35

Donchian pos25.15%

Donchian high15.56

Donchian low10.78

AVWAP (52w high)12.83

vs AVWAP high-6.61%

AVWAP (52w low)7.48

vs AVWAP low+60.27%

OBV trendFlat

Chaikin MF (20)0.01

Today vs 20d0.89×

Avg vol (14d)6.99M

Avg vol (20d)7.26M

Avg $ vol (20d)92.05M

Market cap2.42B

RS Rating99 / 99

RS 3m (vs SPY)+9.33%

RS 6m (vs SPY)+109.31%

RS line new highNo

Trend template7/8

Technical rank74.9

1 week+3.95%

1 month-14.94%

3 months+13.82%

6 months+126.13%

1 year+605.00%

YTD+175.52%

P/E-90.10

P/B17.58

P/S—

P/FCF-85.24

EPS-0.2500

Div yield—

ROE-19.51%

ROA-18.48%

Debt/Eq0.00

Current18.83

EV/EBITDA-81.12

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth13.01%

Price target27.50

Target upside129.45%

Analyst ratingBuy

Institutional40.73%

Ent. value2.28B

Revenue0

Net income-9.61M

Gross profit869K

Free cash flow-28.39M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out196.63M

Employees13

ListedWed, Mar 12, 2008

Free float182.12M

Float %98.7%

Short interest57.93M

Days to cover6.9d

Short volume62.1%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction65 / 100

Pattern quality—

Tech rank74.9 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLS

All disclosures →

No recent disclosed trades by Congress in SLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLS

Insider	Side	Shares	Value	Traded	Filed
Stergiou Angelos M. President and CEO · Common Stock · 2026-06-16	Grant	1.06M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SLS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.